PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Faes Farma's PE Ratio without NRI is 12.72. Faes Farma's 5-Year EBITDA growth rate is 7.60%. Therefore, Faes Farma's PEG Ratio for today is 1.67.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Faes Farma's PEG Ratio or its related term are showing as below:
XMAD:FAE'
s PEG Ratio Range Over the Past 10 Years
Min: 0.77 Med: 1.64 Max: 2.32
Current: 1.67
During the past 13 years, Faes Farma's highest PEG Ratio was 2.32. The lowest was 0.77. And the median was 1.64.
XMAD:FAE's PEG Ratio is ranked better than 51.49% of 369
companies
in the Drug Manufacturers industry
Industry Median: 1.71
vs XMAD:FAE: 1.67
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Faes Farma PEG Ratio Historical Data
The historical data trend for Faes Farma's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Faes Farma's PEG Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Faes Farma's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Faes Farma's PEG Ratio falls into.
Faes Farma PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Faes Farma (XMAD:FAE) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Faes Farma PEG Ratio Related Terms
Thank you for viewing the detailed overview of Faes Farma's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XMAD:FAE has been successfully added to your 